We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Cancer drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Cancer drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Cancer drugs Product List

1～18 item / All 18 items

Displayed results
Tohoku Univ. Technology：A novel therapeutic target Vasohibin-2: T18-447_T12-072

Tohoku Univ. Technology：A novel therapeutic target Vasohibin-2: T18-447_T12-072

For the treatment of refractory cancers including pancreatic cancer

Vasohibin-2 (referred to as VASH2) knockdown significantly reduced metastasis of pancreatic cancer cells (Fig. 1) and prolonged survival period after orthotopic transplantation (Fig.2). The mechanisms of action are;　 (1)VASH2 knockdown reduces cancer cell invasion through suppressing of tubulin carboxypeptidase activity within the cell. (2) VASH2 secreted by cancer cells stimulates tumor angiogenesis, so when VASH2 was knocked down, tumor angiogenesis was prevented. (3) VASH2 regulates the production of inflammatory chemokines and cytokines in cancer cells, which in turn, accelerates the recruitment of MDSC and TAM and prevents the infiltration of cytotoxic T lymphocytes. The inhibition of VASH2 eliminates immune suppression in pancreatic cancer.

  • others
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Testicular Cancer Treatment

[Research Material] Global Market for Testicular Cancer Treatment

Global Market for Testicular Cancer Treatment: Injectables, Oral Medications, Hospital Pharmacies, Retail Pharmacies, Specialized Cancer Clinics, Others

This research report (Global Testicular Cancer Treatment Market) investigates and analyzes the current state and future outlook of the global testicular cancer treatment market over the next five years. It includes information on the overview of the global testicular cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include injectable and oral medications, while the segments by application cover hospital pharmacies, retail pharmacies, specialized cancer clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for testicular cancer treatment. It also provides information on the market share of major companies in testicular cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Colorectal Cancer Treatment

[Research Material] The Global Market for Colorectal Cancer Treatment

Global Market for Colorectal Cancer Treatment: Targeted Therapy, Immunotherapy, Chemotherapy, Others, Hospitals, Clinics

This research report (Global Colorectal Cancer Treatment Market) investigates and analyzes the current state and outlook for the global colorectal cancer treatment market over the next five years. It includes information on the overview of the global colorectal cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the colorectal cancer treatment market include targeted therapy, immunotherapy, chemotherapy, and others, while the segments by application focus on hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for colorectal cancer treatment. It also includes the market share of major companies in colorectal cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ovarian Cancer Treatment Drugs

[Research Material] Global Market for Ovarian Cancer Treatment Drugs

Global Market for Ovarian Cancer Treatments: PARP, PD-L1, Angiogenesis Inhibitors, Hospitals, Research

This research report (Global Ovarian Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for ovarian cancer therapeutics over the next five years. It includes information on the overview of the global ovarian cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on PARP, PD-L1, and angiogenesis inhibitors, while the segments by application target hospitals and research. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ovarian cancer therapeutics. It also includes the market share of major companies in the ovarian cancer therapeutics sector, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Renal Cell Carcinoma Treatment Drugs

[Research Material] Global Market for Renal Cell Carcinoma Treatment Drugs

Global Market for Renal Cell Carcinoma Treatments: Somatostatin Analogues, Targeted Therapies, Chemotherapy, Hospitals, Clinics, Oncology Centers

This research report (Global Renal Cell Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market of renal cell carcinoma treatment drugs over the next five years. It includes information on the overview of the global renal cell carcinoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include somatostatin analogs, targeted therapies, and chemotherapy, while the segments by application focus on hospitals, clinics, and oncology centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of renal cell carcinoma treatment drugs. It also includes the market share of major companies in renal cell carcinoma treatment drugs, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Muscle-Invasive Bladder Cancer Treatment

[Research Material] Global Market for Muscle-Invasive Bladder Cancer Treatment

World Market for Muscle-Invasive Bladder Cancer Treatment: Neoadjuvant Chemotherapy, Postoperative Chemotherapy, Hospitals, Research Institutes, Specialty Clinics

This research report (Global Muscle Invasive Bladder Cancer Treatment Market) investigates and analyzes the current state and outlook for the global market for muscle invasive bladder cancer treatment over the next five years. It includes information on the overview of the global muscle invasive bladder cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the muscle invasive bladder cancer treatment market focus on neoadjuvant chemotherapy and postoperative chemotherapy, while the segments by application target hospitals, laboratories, and specialized clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for muscle invasive bladder cancer treatment. It also includes the market share of major companies in the muscle invasive bladder cancer treatment sector, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Basal Cell Carcinoma (BCC) Treatment Drugs

[Research Material] Global Market for Basal Cell Carcinoma (BCC) Treatment Drugs

World Market for Basal Cell Carcinoma (BCC) Treatment Drugs: Surgery, Radiation Therapy, Photodynamic Therapy, Medications, Retail Pharmacies, Hospital Pharmacies, Cancer Research Institutes

This research report (Global Basal Cell Carcinoma Therapeutics Market) investigates and analyzes the current status and outlook for the global market of basal cell carcinoma (BCC) therapeutics over the next five years. It includes information on the overview of the global basal cell carcinoma (BCC) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for basal cell carcinoma (BCC) therapeutics by type include surgery, radiation therapy, photodynamic therapy, and pharmaceuticals, while the segments by application focus on retail pharmacies, hospital pharmacies, and cancer research institutes. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for basal cell carcinoma (BCC) therapeutics. It also includes the market share of major companies in basal cell carcinoma (BCC) therapeutics, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gallbladder Cancer Treatment

[Research Material] Global Market for Gallbladder Cancer Treatment

Global Market for Gallbladder Cancer Treatment: Apatinib Mesylate, BGBA-317, Binimetinib, Others, Clinics, Hospitals, Others

This research report (Global Gallbladder Cancer Treatment Market) investigates and analyzes the current state and outlook for the global gallbladder cancer treatment market over the next five years. It includes information on the overview of the global gallbladder cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the gallbladder cancer treatment market include mesylate apatinib, BGBA-317, binimetinib, and others, while the segments by application cover clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for gallbladder cancer treatment. It also includes the market share of major companies in gallbladder cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

Head and neck cancer treatment drugs/treatment global market: PD inhibitors, microtubule inhibitors, EGFR inhibitors, surgery, radiation therapy, chemotherapy, immunotherapy.

This research report (Global Head and Neck Cancer Drugs/Therapeutics Market) investigates and analyzes the current status and outlook for the global market of head and neck cancer treatment drugs/therapeutics over the next five years. It includes information on the overview of the global head and neck cancer treatment drugs/therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the head and neck cancer treatment drugs/therapeutics market focus on PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application target surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments calculate the market size for head and neck cancer treatment drugs/therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the head and neck cancer treatment drugs/therapeutics market, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Adrenal Cortical Cancer Treatment Drugs

[Research Material] Global Market for Adrenal Cortical Cancer Treatment Drugs

World Market for Adrenal Cortical Carcinoma Treatment Drugs: Chemotherapy, Targeted Therapy, Hospitals, Research Institutions, Clinics, Others

This research report (Global Adrenocortical Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market for drugs used to treat adrenocortical cancer over the next five years. It includes information on the overview of the global adrenocortical cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on chemotherapy and targeted therapy, while the segments by application target hospitals, research institutions, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for adrenocortical cancer drugs. It also includes the market share of major companies in the adrenocortical cancer drug market, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Castration-Resistant Prostate Cancer

[Research Material] Global Market for Treatment of Castration-Resistant Prostate Cancer

Global Market for Castration-Resistant Prostate Cancer Treatment: Hormonal Therapy, Anti-Androgen Additions, Anti-Androgen Withdrawal, Estrogen, Chemotherapy, Radiation ...

This research report (Global Castration Resistant Prostate Cancer Treatment) investigates and analyzes the current status and outlook for the global market of castration-resistant prostate cancer treatment over the next five years. It includes information on the global overview of the castration-resistant prostate cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the castration-resistant prostate cancer treatment market include hormone therapy, anti-androgen addition, anti-androgen withdrawal, estrogen, chemotherapy, radiation therapy, and others, while the segments by application focus on hospitals and outpatient surgical centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for castration-resistant prostate cancer treatment. The report also includes the market share of major companies in castration-resistant prostate cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Throat Cancer Treatment

[Research Material] Global Market for Throat Cancer Treatment

Global Market for Throat Cancer Treatment: Targeted Therapy, Chemotherapy, Hospitals, Clinics, Others

This research report (Global Pharyngeal Cancer Therapeutics Market) investigates and analyzes the current state and future outlook of the global pharyngeal cancer treatment market over the next five years. It includes information on the overview of the global pharyngeal cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the pharyngeal cancer treatment market focus on targeted therapy and chemotherapy, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for pharyngeal cancer treatment. It also includes the market share of major companies in pharyngeal cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Pancreatic and Bile Duct Cancer Treatments

[Research Material] Global Market for Pancreatic and Bile Duct Cancer Treatments

World Market for Pancreatic and Bile Duct Cancer Treatments: Vascular Endothelial Growth Factor Receptor, Programmed Cell Death Protein 1, Transcription Signal Transducer and Activator of Transcription 3, and others...

This research report (Global Pancreatic and Bile Duct Cancer Drug Market) investigates and analyzes the current status and outlook for the global market for pancreatic and bile duct cancer treatment drugs over the next five years. It includes information on the overview of the global pancreatic and bile duct cancer treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include vascular endothelial growth factor receptor, programmed cell death protein 1, transcription signal transducer and activator of transcription 3, and others, while the segments by application focus on pancreatic cancer and bile duct cancer. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for pancreatic and bile duct cancer treatment drugs. It also includes the market share of major companies in pancreatic and bile duct cancer treatment drugs, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Small Molecule Cancer Therapies

[Research Material] Global Market for Small Molecule Cancer Therapies

Global Market for Small Molecule Cancer Therapies: Cytokines, Humanized Monoclonal Antibodies, Others, Lymphoma, Myeloma, Prostate Cancer, Others

This research report (Global Small Molecule Cancer Drug Market) investigates and analyzes the current state and outlook for the global small molecule cancer treatment drug market over the next five years. It includes information on the overview of the global small molecule cancer treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the small molecule cancer treatment drug market focus on cytokines, humanized monoclonal antibodies, and others, while the segments by application target lymphoma, myeloma, prostate cancer, and others. The regional segments calculate the market size of small molecule cancer treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in small molecule cancer treatment drugs, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Non-Melanoma Skin Cancer Treatment

[Research Material] Global Market for Non-Melanoma Skin Cancer Treatment

World Market for Non-Melanoma Skin Cancer Treatment: Chemotherapy, Radiation Therapy, Photodynamic Therapy, Hospitals, Clinics, Outpatient Surgery Centers, Others

This research report (Global Non-Melanoma Skin Cancer Treatment Market) investigates and analyzes the current status and outlook for the global market for non-melanoma skin cancer treatment over the next five years. It includes information on the overview of the global non-melanoma skin cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the non-melanoma skin cancer treatment market by type include chemotherapy, radiation therapy, and photodynamic therapy, while the segments by application focus on hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for non-melanoma skin cancer treatment. It also includes the market share of major companies in non-melanoma skin cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Oral Cancer Treatment

[Research Material] Global Market for Oral Cancer Treatment

Global Market for Oral Cancer Treatment: Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Cancer, Lymphoma, Hospitals & Clinics, Research Institutions, Academic Institutions

This research report (Global Oral Cancer Treatment Market) investigates and analyzes the current status and outlook for the global oral cancer treatment market over the next five years. It includes information on the overview of the global oral cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral cancer treatment market include squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinoma, and lymphoma, while the segments by application focus on hospitals/clinics, research institutions, and academic institutions. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for oral cancer treatment. It also includes the market share of major companies in oral cancer treatment, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Head and Neck Cancer Treatments

[Research Material] Global Market for Head and Neck Cancer Treatments

Global Market for Head and Neck Cancer Treatments: PD Inhibitors, Microtubule Inhibitors, EGFR Inhibitors, Surgery, Radiation Therapy, Chemotherapy, Immunotherapy

This research report (Global Head and Neck Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for head and neck cancer therapeutics over the next five years. It includes information on the overview of the global head and neck cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application focus on surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for head and neck cancer therapeutics. It also includes the market share of major companies in head and neck cancer therapeutics, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Skin Cancer Treatment

[Market Report] Global Market for Skin Cancer Treatment

The global market for skin cancer treatment is rapidly expanding and is expected to reach 14.5 billion USD by 2031.

As the battle against skin cancer, one of the most common cancers, continues, the global skin cancer treatment market is emerging as a bastion of hope. This market recorded a solid revenue of approximately 7.72 billion USD in 2022 and is expected to achieve a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2023 to 2031, indicating remarkable growth. By 2031, it is projected to reach an astonishing valuation of 14.5 billion USD. Skin cancer is often caused by excessive sunbathing and ultraviolet rays, and there is growing global concern about it. The rising incidence of skin cancer and increasing awareness of the importance of early diagnosis and treatment are driving demand for advanced and effective skin cancer treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Cancer drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.